Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer.

Lindeman GJ, Lok SW, Whittle JR, Vaillant F, Teh CE, Lo LL, Policheni AN, Bergin ART, Desai J, Ftouni S, Gandolfo LC, Liew D, Liu HK, Mann GB, Moodie K, Murugasu A, Pal B, Roberts AW, Rosenthal MA, Shackleton K, Silva MJ, Siow ZR, Smyth GK, Taylor L, Travers A, Yeo B, Yeung MM, Zivanovic Bujak A, Dawson SJ, Gray DHD, Visvader JE.

Cancer Discov. 2018 Dec 5. pii: CD-18-1151. doi: 10.1158/2159-8290.CD-18-1151. [Epub ahead of print]

PMID:
30518523
2.

Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis.

Bergin ART, Hovey E, Lloyd A, Marx G, Parente P, Rapke T, de Souza P.

Support Care Cancer. 2017 Sep;25(9):2871-2879. doi: 10.1007/s00520-017-3706-8. Epub 2017 Apr 20.

PMID:
28429147
3.

Improving door-to-balloon times in Asia for acute ST elevation myocardial infarction via direct activation by emergency physicians of percutaneous coronary intervention.

Ong ME, Wong AS, Chan KP, Bergin AR, Sultana P, Lim SH, Chua TS, Lim ST, Chin CT, Pek PP, Venkataraman A.

Int J Cardiol. 2010 Dec 3;145(3):613-4. doi: 10.1016/j.ijcard.2010.09.030. Epub 2010 Oct 14. No abstract available.

PMID:
20950872

Supplemental Content

Loading ...
Support Center